These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pioneering the implementation of a precision oncology strategy in Portugal: the Precision Oncology Platform trial. Mainoli B; Assis J; Dinis J; Henrique R; Oliveira J Acta Oncol; 2024 Jun; 63():482-486. PubMed ID: 38910310 [TBL] [Abstract][Full Text] [Related]
7. Digital ECMT Cancer Trial Matching Tool: an Open Source Research Application to Support Oncologists in the Identification of Precision Medicine Clinical Trials. O'Regan P; Hoskins R; Grave C; Stevenson JA; Frost H; Graham DM; Krebs MG; Freitas A; Landers D JCO Clin Cancer Inform; 2023 Jan; 7():e2200137. PubMed ID: 36657092 [TBL] [Abstract][Full Text] [Related]
8. Basket Studies: Redefining Clinical Trials in the Era of Genome-Driven Oncology. Tao JJ; Schram AM; Hyman DM Annu Rev Med; 2018 Jan; 69():319-331. PubMed ID: 29120700 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. The clinical trial landscape in oncology and connectivity of somatic mutational profiles to targeted therapies. Patterson SE; Liu R; Statz CM; Durkin D; Lakshminarayana A; Mockus SM Hum Genomics; 2016 Jan; 10():4. PubMed ID: 26772741 [TBL] [Abstract][Full Text] [Related]
11. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology. Janiaud P; Serghiou S; Ioannidis JPA Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165 [TBL] [Abstract][Full Text] [Related]
12. Leveraging Large Language Models for Decision Support in Personalized Oncology. Benary M; Wang XD; Schmidt M; Soll D; Hilfenhaus G; Nassir M; Sigler C; Knödler M; Keller U; Beule D; Keilholz U; Leser U; Rieke DT JAMA Netw Open; 2023 Nov; 6(11):e2343689. PubMed ID: 37976064 [TBL] [Abstract][Full Text] [Related]
13. Molecular tests and target therapies in oncology: recommendations from the Italian workshop. Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524 [TBL] [Abstract][Full Text] [Related]
14. Innovative trial design in precision oncology. Tsimberidou AM; Müller P; Ji Y Semin Cancer Biol; 2022 Sep; 84():284-292. PubMed ID: 33022355 [TBL] [Abstract][Full Text] [Related]
15. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards. Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535 [TBL] [Abstract][Full Text] [Related]
16. Precision medicine in pediatric oncology. Forrest SJ; Geoerger B; Janeway KA Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430 [TBL] [Abstract][Full Text] [Related]
17. Precision oncology based on omics data: The NCT Heidelberg experience. Horak P; Klink B; Heining C; Gröschel S; Hutter B; Fröhlich M; Uhrig S; Hübschmann D; Schlesner M; Eils R; Richter D; Pfütze K; Geörg C; Meißburger B; Wolf S; Schulz A; Penzel R; Herpel E; Kirchner M; Lier A; Endris V; Singer S; Schirmacher P; Weichert W; Stenzinger A; Schlenk RF; Schröck E; Brors B; von Kalle C; Glimm H; Fröhling S Int J Cancer; 2017 Sep; 141(5):877-886. PubMed ID: 28597939 [TBL] [Abstract][Full Text] [Related]
18. The My Cancer Genome clinical trial data model and trial curation workflow. Jain N; Mittendorf KF; Holt M; Lenoue-Newton M; Maurer I; Miller C; Stachowiak M; Botyrius M; Cole J; Micheel C; Levy M J Am Med Inform Assoc; 2020 Jul; 27(7):1057-1066. PubMed ID: 32483629 [TBL] [Abstract][Full Text] [Related]
19. Umbrella and basket trials in oncology: ethical challenges. Strzebonska K; Waligora M BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704 [TBL] [Abstract][Full Text] [Related]
20. Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design. Fountzilas E; Tsimberidou AM; Hiep Vo H; Kurzrock R Cancer Treat Rev; 2024 Apr; 125():102703. PubMed ID: 38484408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]